Global Transforming Growth Factor Beta 1 Market Professional Survey Report 2019
Table of Contents
Executive Summary
1 Industry Overview of Transforming Growth Factor Beta 1
- 1.1 Definition of Transforming Growth Factor Beta 1
- 1.2 Transforming Growth Factor Beta 1 Segment by Type
- 1.2.1 Global Transforming Growth Factor Beta 1 Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 AVID-200
- 1.2.3 Decorin
- 1.2.4 Engedi-1000
- 1.2.5 Fresolimumab
- 1.2.6 Others
- 1.3 Transforming Growth Factor Beta 1 Segment by Applications
- 1.3.1 Global Transforming Growth Factor Beta 1 Consumption Comparison by Applications (2014-2025)
- 1.3.2 Osteoarthritis
- 1.3.3 Acute Pain
- 1.3.4 Autoimmune Disorders
- 1.3.5 Breast Cancer
- 1.3.6 Others
- 1.4 Global Transforming Growth Factor Beta 1 Overall Market
- 1.4.1 Global Transforming Growth Factor Beta 1 Revenue (2014-2025)
- 1.4.2 Global Transforming Growth Factor Beta 1 Production (2014-2025)
- 1.4.3 North America Transforming Growth Factor Beta 1 Status and Prospect (2014-2025)
- 1.4.4 Europe Transforming Growth Factor Beta 1 Status and Prospect (2014-2025)
- 1.4.5 China Transforming Growth Factor Beta 1 Status and Prospect (2014-2025)
- 1.4.6 Japan Transforming Growth Factor Beta 1 Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Transforming Growth Factor Beta 1 Status and Prospect (2014-2025)
- 1.4.8 India Transforming Growth Factor Beta 1 Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Transforming Growth Factor Beta 1
- 2.3 Manufacturing Process Analysis of Transforming Growth Factor Beta 1
- 2.4 Industry Chain Structure of Transforming Growth Factor Beta 1
3 Development and Manufacturing Plants Analysis of Transforming Growth Factor Beta 1
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Transforming Growth Factor Beta 1 Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Transforming Growth Factor Beta 1
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Transforming Growth Factor Beta 1 Production and Capacity Analysis
- 4.2 Transforming Growth Factor Beta 1 Revenue Analysis
- 4.3 Transforming Growth Factor Beta 1 Price Analysis
- 4.4 Market Concentration Degree
5 Transforming Growth Factor Beta 1 Regional Market Analysis
- 5.1 Transforming Growth Factor Beta 1 Production by Regions
- 5.1.1 Global Transforming Growth Factor Beta 1 Production by Regions
- 5.1.2 Global Transforming Growth Factor Beta 1 Revenue by Regions
- 5.2 Transforming Growth Factor Beta 1 Consumption by Regions
- 5.3 North America Transforming Growth Factor Beta 1 Market Analysis
- 5.3.1 North America Transforming Growth Factor Beta 1 Production
- 5.3.2 North America Transforming Growth Factor Beta 1 Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Transforming Growth Factor Beta 1 Import and Export
- 5.4 Europe Transforming Growth Factor Beta 1 Market Analysis
- 5.4.1 Europe Transforming Growth Factor Beta 1 Production
- 5.4.2 Europe Transforming Growth Factor Beta 1 Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Transforming Growth Factor Beta 1 Import and Export
- 5.5 China Transforming Growth Factor Beta 1 Market Analysis
- 5.5.1 China Transforming Growth Factor Beta 1 Production
- 5.5.2 China Transforming Growth Factor Beta 1 Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Transforming Growth Factor Beta 1 Import and Export
- 5.6 Japan Transforming Growth Factor Beta 1 Market Analysis
- 5.6.1 Japan Transforming Growth Factor Beta 1 Production
- 5.6.2 Japan Transforming Growth Factor Beta 1 Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Transforming Growth Factor Beta 1 Import and Export
- 5.7 Southeast Asia Transforming Growth Factor Beta 1 Market Analysis
- 5.7.1 Southeast Asia Transforming Growth Factor Beta 1 Production
- 5.7.2 Southeast Asia Transforming Growth Factor Beta 1 Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Transforming Growth Factor Beta 1 Import and Export
- 5.8 India Transforming Growth Factor Beta 1 Market Analysis
- 5.8.1 India Transforming Growth Factor Beta 1 Production
- 5.8.2 India Transforming Growth Factor Beta 1 Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Transforming Growth Factor Beta 1 Import and Export
6 Transforming Growth Factor Beta 1 Segment Market Analysis (by Type)
- 6.1 Global Transforming Growth Factor Beta 1 Production by Type
- 6.2 Global Transforming Growth Factor Beta 1 Revenue by Type
- 6.3 Transforming Growth Factor Beta 1 Price by Type
7 Transforming Growth Factor Beta 1 Segment Market Analysis (by Application)
- 7.1 Global Transforming Growth Factor Beta 1 Consumption by Application
- 7.2 Global Transforming Growth Factor Beta 1 Consumption Market Share by Application (2014-2019)
8 Transforming Growth Factor Beta 1 Major Manufacturers Analysis
- 8.1 Acceleron Pharma Inc
- 8.1.1 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Production Sites and Area Served
- 8.1.2 Acceleron Pharma Inc Product Introduction, Application and Specification
- 8.1.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Eli Lilly and Co
- 8.2.1 Eli Lilly and Co Transforming Growth Factor Beta 1 Production Sites and Area Served
- 8.2.2 Eli Lilly and Co Product Introduction, Application and Specification
- 8.2.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Ensol Biosciences Inc
- 8.3.1 Ensol Biosciences Inc Transforming Growth Factor Beta 1 Production Sites and Area Served
- 8.3.2 Ensol Biosciences Inc Product Introduction, Application and Specification
- 8.3.3 Ensol Biosciences Inc Transforming Growth Factor Beta 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Formation Biologics Inc
- 8.4.1 Formation Biologics Inc Transforming Growth Factor Beta 1 Production Sites and Area Served
- 8.4.2 Formation Biologics Inc Product Introduction, Application and Specification
- 8.4.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Genzyme Corp
- 8.5.1 Genzyme Corp Transforming Growth Factor Beta 1 Production Sites and Area Served
- 8.5.2 Genzyme Corp Product Introduction, Application and Specification
- 8.5.3 Genzyme Corp Transforming Growth Factor Beta 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Huabo Biopharm Co Ltd
- 8.6.1 Huabo Biopharm Co Ltd Transforming Growth Factor Beta 1 Production Sites and Area Served
- 8.6.2 Huabo Biopharm Co Ltd Product Introduction, Application and Specification
- 8.6.3 Huabo Biopharm Co Ltd Transforming Growth Factor Beta 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Isarna Therapeutics GmbH
- 8.7.1 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Production Sites and Area Served
- 8.7.2 Isarna Therapeutics GmbH Product Introduction, Application and Specification
- 8.7.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Johnson & Johnson
- 8.8.1 Johnson & Johnson Transforming Growth Factor Beta 1 Production Sites and Area Served
- 8.8.2 Johnson & Johnson Product Introduction, Application and Specification
- 8.8.3 Johnson & Johnson Transforming Growth Factor Beta 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Novartis AG
- 8.9.1 Novartis AG Transforming Growth Factor Beta 1 Production Sites and Area Served
- 8.9.2 Novartis AG Product Introduction, Application and Specification
- 8.9.3 Novartis AG Transforming Growth Factor Beta 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Scholar Rock Inc
- 8.10.1 Scholar Rock Inc Transforming Growth Factor Beta 1 Production Sites and Area Served
- 8.10.2 Scholar Rock Inc Product Introduction, Application and Specification
- 8.10.3 Scholar Rock Inc Transforming Growth Factor Beta 1 Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Sirnaomics Inc
9 Development Trend of Analysis of Transforming Growth Factor Beta 1 Market
- 9.1 Global Transforming Growth Factor Beta 1 Market Trend Analysis
- 9.1.1 Global Transforming Growth Factor Beta 1 Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Transforming Growth Factor Beta 1 Regional Market Trend
- 9.2.1 North America Transforming Growth Factor Beta 1 Forecast 2019-2025
- 9.2.2 Europe Transforming Growth Factor Beta 1 Forecast 2019-2025
- 9.2.3 China Transforming Growth Factor Beta 1 Forecast 2019-2025
- 9.2.4 Japan Transforming Growth Factor Beta 1 Forecast 2019-2025
- 9.2.5 Southeast Asia Transforming Growth Factor Beta 1 Forecast 2019-2025
- 9.2.6 India Transforming Growth Factor Beta 1 Forecast 2019-2025
- 9.3 Transforming Growth Factor Beta 1 Market Trend (Product Type)
- 9.4 Transforming Growth Factor Beta 1 Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Transforming Growth Factor Beta 1 Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
The global Transforming Growth Factor Beta 1 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Transforming Growth Factor Beta 1 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Transforming Growth Factor Beta 1 market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Transforming Growth Factor Beta 1 in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Transforming Growth Factor Beta 1 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Acceleron Pharma Inc
Eli Lilly and Co
Ensol Biosciences Inc
Formation Biologics Inc
Genzyme Corp
Huabo Biopharm Co Ltd
Isarna Therapeutics GmbH
Johnson & Johnson
Novartis AG
Scholar Rock Inc
Sirnaomics Inc
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
AVID-200
Decorin
Engedi-1000
Fresolimumab
Others
Segment by Application
Osteoarthritis
Acute Pain
Autoimmune Disorders
Breast Cancer
Others